Skip to content
JaxBio logo — At JaxBio we develop a blood test for fast, cheap and highly...

JaxBio

At JaxBio we develop a blood test for fast, cheap and highly sensitive diagnosis of cancer.

Founded 2022 11 employees Grant Total: $2.50M Health Care

General Information

Company Name JaxBio
Founded Year 2022
Employees 11
Industries Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with JaxBio. To contact JaxBio, visit jaxbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does JaxBio compare?

A PDF of JaxBio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting JaxBio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About JaxBio

JaxBio is a pioneering company in the healthcare industry, dedicated to transforming cancer diagnosis and management with their innovative blood test technology. The company's slogan "At JaxBio we develop a blood test for fast, cheap, and highly sensitive diagnosis of cancer" encapsulates their mission to simplify, expedite, and enhance the precision of cancer detection. Their groundbreaking blood test offers a significant advancement over traditional methods and liquid biopsies, delivering faster and more accurate results at a lower cost. Utilizing state-of-the-art artificial intelligence (AI) algorithms, JaxBio identifies effective biomarker sets that efficiently detect various types and subtypes of cancer at different stages. The company's impact extends beyond initial diagnosis, as their tests play a crucial role in monitoring disease status and forecasting patient response to therapy. Notably, JaxBio's platform technology has potential applications in a spectrum of diseases, including various cancer types, neurodegenerative diseases, and heart conditions. The latest investment of $2.50 million from the EIC Accelerator in July 2024 signifies a significant endorsement of JaxBio's groundbreaking approach to cancer diagnosis. As JaxBio continues to innovate and evolve, their disruptive blood test technology promises to empower healthcare providers and patients with timely and informed decision-making in critical moments. For more insights, consider engaging with JaxBio directly.

Business keywords: Health Diagnostics, Cancer Diagnostics, Early Cancer Detection, Disease Monitoring, Artificial Intelligence in Healthcare, Precision Medicine, Healthcare Innovation, Blood Test, DNA Medical Kit, Lung Cancer, Haematological Malignancies, Lymphoma, Multiple Myeloma, Biomarkers, Liquid Biopsy

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $2.50M 1
EIC Accelerator
16 Jul 2024

JaxBio Alternatives & Competitors

View All Alternatives
JaxBio vs

Our company is using AI and Digital Automation to make early cancer diagnostics a routine.

Grant
5 employees
AI, Health Care
JaxBio vs

ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HGPCa and gu...

Series C
103 employees
Biotechnology, Health Care
JaxBio vs
Owlstone Medical
Owlstone Medical United Kingdom

On a mission to save 100k lives and $1.5B healthcare costs

149 employees
Health Care, Medical Devices

FAQ About JaxBio

At JaxBio we develop a blood test for fast, cheap and highly sensitive diagnosis of cancer.
JaxBio was founded in 2022.
JaxBio operates in Health Care. Its work centres on Health Diagnostics, Cancer Diagnostics, Early Cancer Detection and Disease Monitoring.
JaxBio has approximately 11 employees.
JaxBio has completed 1 funding round, raising a total of $2.50M. The latest funding stage is Grant.
Top alternatives and competitors to JaxBio include Artificial Intelligence Expert, Exosome Diagnostics, a Bio-Techne brand, Owlstone Medical, CellMax Life, Lucence. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
JaxBio and Artificial Intelligence Expert are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for JaxBio, https://bouncewatch.com/company/jaxbio, updated 5 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout